NCT00565370 2020-01-18Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XPAsan Medical CenterPhase 1/2 Completed22 enrolled 11 charts
NCT00253370 2014-11-24Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerNational Cancer Institute (NCI)Phase 2 Completed44 enrolled 8 charts